SHAARE ZEDEK MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1902-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.szmc.org.il
Clinical Trials
191
Active:1
Completed:64
Trial Phases
6 Phases
Early Phase 1:4
Phase 1:4
Phase 2:21
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (133 trials with phase data)• Click on a phase to view related trials
Not Applicable
69 (51.9%)Phase 2
21 (15.8%)Phase 4
20 (15.0%)Phase 3
15 (11.3%)Early Phase 1
4 (3.0%)Phase 1
4 (3.0%)Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus Progesterone
Early Phase 1
Not yet recruiting
- Conditions
- IvfFrozen Embryo Transfer (FET)
- Interventions
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT06870266
Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open Label Pilot Study
Early Phase 1
Not yet recruiting
- Conditions
- Fecal Incontinence
- Interventions
- Drug: Botulinum Toxin A (Botox )
- First Posted Date
- 2025-01-21
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT06785844
Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC
Not Applicable
Completed
- Conditions
- Ulcerative ColitisInflammatory Bowel Diseases
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT06777706
- Locations
- 🇮🇱
Shaare Zedek Medical Center - The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition, Jerusalem, Israel
🇮🇱Schneider Children's Medical Center, Petah tikva, Israel
Tolerability of Baked Dairy Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger
Not Applicable
- Conditions
- Eosinophilic Esophagitis (EoE)
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT06756581
- Locations
- 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel
The Effect of Uroshield on Sputum-specimen Bacterial Growth
Not Applicable
Completed
- Conditions
- Mechanically Ventilated Patients
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 48
- Registration Number
- NCT06729476
- Prev
- 1
- 2
- 3
- 4
- 5
- 38
- Next
News
Merck KGaA Joins Peregrine Ventures' Incentive Incubator as Strategic Partner
Merck KGaA has become a strategic partner in Peregrine Ventures' Incentive Incubator, gaining early access to startups in bioconvergence, pharma, and biotechnology fields.